Managing your healthcare is moving increasingly to the palm of your hand — with new smartphone-enabled technology and wearable sensors that examine, diagnose and even treat many conditions and ailments.
The Consumer Electronics Show (CES) in Las Vegas saw the debut of new applications for “virtual checkups” and ways to treat pain, manage stress and monitor conditions such as diabetes.
French-based health group VisioMed introduced its Bewell Connect health management suite, which includes a smartphone app that communicates with its connected blood pressure and glucose monitor, thermometer and blood oxygen sensor.
Photo: AFP
“If I have all these indicators, I can get a pretty good assessment of your health,” VisioMed research director Benjamin Pennequin said. “This is like a personal virtual checkup.”
However, the app goes further: If you have symptoms such as chest pain or shortness of breath, it poses a series of questions and delivers potential diagnoses, and allows the user to share the data with a physician.
And a simple button on the app can connect you to a doctor: In France the app locates nearby providers in the national medical service, and Bewell is working to establish a network of connected physicians in the US.
Photo: Reuters
A hand-held connected device unveiled by Las Vegas-based startup MedWand allows consumers to measure temperature, heart rate, oxygen levels and includes a camera to examine the throat and inner ear to enable doctors to perform an exam online.
Lead engineer Terry MacNeish said the data from the US$250 gadget allows for a more thorough exam than most other kinds of telemedicine.
“If you’re just Skyping your doctor, it’s just medical chat,” MacNeish said. “With this, we can get a picture of your tonsils, we can take your temperature. It’s much more precise.”
MedWand is in the pre-approval phase for clearance by the US Food and Drug Administration, and is expected to complete the process this year, inventor and CEO Samir Qamar said.
MedWand is working with existing telemedicine doctors and hopes to start selling the device in June in the US and globally.
MacNeish said insurance companies are generally positive towards the product because a telemedicine exam costs less than one in a doctor’s office.
“The patient saves a lot of time and so does the doctor,” he said.
Putting more health data in consumers’ hands is a big theme at CES.
US-based medical device maker Omron unveiled its wrist-worn blood pressure sensor that delivers information to a smartphone.
“Most people only get their blood pressure checked at the doctor’s office once or twice a year,” chief operating officer Ranndy Kellogg said. “This is continuous monitoring. If there is something wrong with your heart, you really want to listen.”
Tech-savvy startups and others are introducing new ways to treat pain, in some cases taking techniques that have been around for decades and adapting them for smartphones and connected wearables.
NeuroMetrix debuted its Quell leg band, which blocks pain signals to the brain, and is an alternative to drugs for people suffering from debilitating pain related to diabetes or other ailments. It recently received approval from the US Food and Drug Administration.
NeuroMetrix founder Shai Gozani, a medical doctor who also has a doctorate in neurobiology, said the device “triggers your brain to upgrade its pain modulation” by acting on the opioid receptors in the same manner as opiates — but without drugs.
While Quell is a device which treats pain anywhere in the body from a single band, iTens offers a smartphone-controlled patch which attaches to specific muscles to treat pain, using technology known as TENS, or transcutaneous elenctical neuromuscular stimulation.
The technology has been around for decades in hospital settings, but is only now hitting the consumer market with smartphone technology and sensor-embedded devices.
“The electrical impulse intercepts the pain signal before it reaches the brain,” iTens spokesman Scott Overton said while showing the device on the CES floor.
Tech innovators have found other paths to effectively hack into the body’s neural pathways for therapy.
Biotrak Health showcased a headband to help users control muscle tension that often leads to migraines and other kinds of pain.
The Halo headband “alerts you when you are tense and allows you to control your own tension,” spokesman Adam Kirell said.
Meanwhile, a wrist-worn device from ReliefBand technologies takes aim at nausea associated with motion and morning sickness. The device, which looks like a wristwatch, acts on the P6 or median nerve — the same technique used in centuries-old treatment from acupuncture.
Charming US President Donald Trump one week, angering China the next, Japanese Prime Minister Sanae Takaichi has had a busy start and is riding high in the polls, all on a few hours of sleep a night. However, the honeymoon might end soon for the Margaret Thatcher-admiring leader if a spat with China escalates further and she fails to keep inflation in check. “I believe Prime Minister Takaichi will surely do what she needs to do, so I trust her,” Kozue Otsuka, 50, told reporters at a festival this week for business owners seeking good fortune. While buying a lucky kumade rake featuring
TECH TITANS: Amazon’s latest chip joins Google in competing for the 90 percent market share held by Nvidia, which claims it is ‘a generation ahead of the industry’ Amazon Web Services (AWS) on Tuesday launched its in-house-built Trainium3 artificial intelligence (AI) chip, marking a significant push to compete with Nvidia Corp in the lucrative market for AI computing power. The move intensifies competition in the AI chip market, where Nvidia dominates with an estimated 80 to 90 percent market share for products used in training large language models that power the likes of ChatGPT. Google last week caused tremors in the industry when it was reported that Facebook-parent Meta Platforms Inc would employ Google AI chips in data centers, signaling new competition for Nvidia. This followed the release last month of
INSULATED: The company said it is less exposed to global complications, as it has built a strong footprint worldwide, and has multiple sources of rare earths and raw minerals Merck Group yesterday said it would ramp up production next year at its new flagship facility in Kaohsiung’s Lujhu District (路竹) to satisfy growing demand for advanced semiconductor materials and specialty gases, and to address supply resilience issues amid mounting geopolitical risks. Merck made the remarks during a news conference before the inauguration of its 500 million euros (US$582.1 million) facility, which is also to supply other markets in the Asia-Pacific region, it said. Merck executive board deputy chair and electronics CEO Kai Beckmann told reporters the company adopted a “local-for-local” strategy about seven years ago to address the cycle time of
Two companies wholly owned by the daughter of the founder of Hon Hai Precision Industry Co (鴻海精密) on Monday reported to the Taiwan Stock Exchange that they would dispose of all of the Hon Hai shares they hold. In filings with the exchange, Hong Wei Investment Co (鋐維) said it would sell the 2.771 million Hon Hai shares it holds and Frontier Investment Corp (承鋒投資) said it would sell its 2.409 million Hon Hai shares from tomorrow until Jan. 3 next year. The two companies are wholly owned and chaired by Shirley Gou (郭曉玲), the eldest daughter of Hon Hai founder Terry
RSS